TBC1D3 Antikörper (C-Term)
Kurzübersicht für TBC1D3 Antikörper (C-Term) (ABIN7185578)
Target
Alle TBC1D3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- TBC1D3/TBC1D3B/TBC1D3C Antibody
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human TBC1D3A/B/C.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TBC1D3 (TBC1 Domain Family, Member 3 (TBC1D3))
-
Andere Bezeichnung
- TBC1D3
-
Hintergrund
- TBC1D3, PRC17, TBC1D3A, TBC1 domain family member 3, Prostate cancer gene 17 protein, Protein TRE17-alpha, Rab GTPase-activating protein PRC17, TBC1D3B, TBC1D3I, TBC1 domain family member 3B, TBC1D3C, TBC1D3D, TBC1 domain family member 3C
-
UniProt
- Q8IZP1, A6NDS4, Q6IPX1
Target
-